glucokinase activator (Prosidion)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameglucokinase activator (Prosidion)
Drug Alias Nameglucokinase activator (Prosidion)PSN-GK1PSN-105
ClassificationSmall molecules
Mechanisms of ActionInsulin sensitizersInsulin release stimulantsGlucokinase activators
TargetsGlucokinaseInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProsidion Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProsidion Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A